193 related articles for article (PubMed ID: 20446891)
1. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.
Andersson U; Schwartzbaum J; Wiklund F; Sjöström S; Liu Y; Tsavachidis S; Ahlbom A; Auvinen A; Collatz-Laier H; Feychting M; Johansen C; Kiuru A; Lönn S; Schoemaker MJ; Swerdlow AJ; Henriksson R; Bondy M; Melin B
Acta Oncol; 2010 Aug; 49(6):767-75. PubMed ID: 20446891
[TBL] [Abstract][Full Text] [Related]
2. Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study.
Späth F; Andersson U; Dahlin AM; Langseth H; Hovig E; Johannesen TB; Grankvist K; Björkblom B; Wibom C; Melin B
Tumour Biol; 2016 Aug; 37(8):11065-72. PubMed ID: 26906551
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in EGF and EGFR and glioblastoma outcome.
Sjöström S; Andersson U; Liu Y; Brännström T; Broholm H; Johansen C; Collatz-Laier H; Henriksson R; Bondy M; Melin B
Neuro Oncol; 2010 Aug; 12(8):815-21. PubMed ID: 20197289
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the EGFR gene and the risk of glioma in a Chinese Han population.
Hou WG; Ai WB; Bai XG; Dong HL; Li Z; Zhang YQ; Xiong LZ
PLoS One; 2012; 7(5):e37531. PubMed ID: 22662167
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer.
Ma D; Hovey RL; Zhang Z; Fye S; Huettner PC; Borecki IB; Rader JS
Gynecol Oncol; 2013 Nov; 131(2):445-50. PubMed ID: 23927961
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic variants in the retinoblastoma binding protein 6 gene with the risk of glioma: a case-control study in a Chinese Han population.
Hu D; Zhang S; Zhao Y; Wang S; Wang Q; Song X; Lu D; Mao Y; Chen H
J Neurosurg; 2014 Nov; 121(5):1209-18. PubMed ID: 25127414
[TBL] [Abstract][Full Text] [Related]
7. Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population.
Baek IK; Cheong HS; Namgoong S; Kim JH; Kang SG; Yoon SJ; Kim SH; Chang JH; Kim LH; Shin HD
Sci Rep; 2022 Nov; 12(1):19014. PubMed ID: 36347915
[TBL] [Abstract][Full Text] [Related]
8. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & -191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA.
Zahoor W; Pandith AA; Nisar S; Qasim I; Surana M; Ganie FA; Manzoor U; Arif SH; Rasool SUA; Lateef A; Shah P; Bhat RA
Exp Oncol; 2023 Oct; 45(2):203-210. PubMed ID: 37824771
[TBL] [Abstract][Full Text] [Related]
9. Impact of EGFR genetic variants on glioma risk and patient outcome.
Costa BM; Viana-Pereira M; Fernandes R; Costa S; Linhares P; Vaz R; Pinheiro C; Lima J; Soares P; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires MM; Pinheiro C; Carvalho E; Oliveira P; Lopes JM; Reis RM
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2610-7. PubMed ID: 21960689
[TBL] [Abstract][Full Text] [Related]
10. The expression and prognostic value of the epidermal growth factor receptor family in glioma.
Xu B; Huo Z; Huang H; Ji W; Bian Z; Jiao J; Sun J; Shao J
BMC Cancer; 2021 Apr; 21(1):451. PubMed ID: 33892666
[TBL] [Abstract][Full Text] [Related]
11. Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.
Meng LQ
Tumour Biol; 2014 Dec; 35(12):12497-508. PubMed ID: 25217982
[TBL] [Abstract][Full Text] [Related]
12. Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.
Melin B; Dahlin AM; Andersson U; Wang Z; Henriksson R; Hallmans G; Bondy ML; Johansen C; Feychting M; Ahlbom A; Kitahara CM; Wang SS; Ruder AM; Carreón T; Butler MA; Inskip PD; Purdue M; Hsing AW; Mechanic L; Gillanders E; Yeager M; Linet M; Chanock SJ; Hartge P; Rajaraman P
Int J Cancer; 2013 May; 132(10):2464-8. PubMed ID: 23115063
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic polymorphisms of EGFR with glioma in a Chinese population.
Wang X; Zhang H; Wang D; Li X
Genet Test Mol Biomarkers; 2015 Jan; 19(1):59-62. PubMed ID: 25514356
[TBL] [Abstract][Full Text] [Related]
14. Association between EGF +61 G/A and glioma risk in a Chinese population.
Wang S; Zhao Y; Ruan Z; Chen H; Fan W; Chen J; Wu Q; Qian J; Zhang T; Huang Y; Lu D
BMC Cancer; 2010 May; 10():221. PubMed ID: 20487573
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 and XRCC3 variants and risk of glioma and meningioma.
Kiuru A; Lindholm C; Heinävaara S; Ilus T; Jokinen P; Haapasalo H; Salminen T; Christensen HC; Feychting M; Johansen C; Lönn S; Malmer B; Schoemaker MJ; Swerdlow AJ; Auvinen A
J Neurooncol; 2008 Jun; 88(2):135-42. PubMed ID: 18330515
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
[TBL] [Abstract][Full Text] [Related]
18. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
19. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
20. Possible association between genetic variants in the H2AFX promoter region and risk of adult glioma in a Chinese Han population.
Fan W; Zhou K; Zhao Y; Wu W; Chen H; Jin L; Chen G; Shi J; Wei Q; Zhang T; Du G; Mao Y; Lu D; Zhou L
J Neurooncol; 2011 Nov; 105(2):211-8. PubMed ID: 21512825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
